Symrise AG has signed a minority investment agreement with Bonumose. The early-stage food ingredient manufacturer specializes in the affordable production of delicious, good-for-you rare monosaccharides (alternatives to sucrose) such as...
Bonumose says FDA Sides With High Fructose Corn Syrup Producers and Against Consumers, By Suppressing Truthful Information About Tagatose
Internal FDA documents discovered via the Freedom of Information Act indicate a potential FDA bias against health-focused innovation and in favor of industrial corn sweetener producers.
Bonumose's Low-Cost Tagatose Process Receives Key Health Agency Approvals, Construction of First Production Facility on Schedule for Spring 2022 Opening
ASR Group – exclusive sales and distribution partner – reports strong customer demand for the unique, rare sugar, accelerating the timeline for a second production plant.
Bonumose is pleased to announce the issuance of U.S. Patent No. 11,078,506 for “Enzymatic Production of D-Allulose”.
Bonumose Biochem was selected as one of 24 early-stage companies to present at the Council for Entrepreneurial Development’s Life Science Conference 2017, to be held February 28-March 1 in Raleigh,...